Multicentre Retrospective Study on the Clinical and Epidemiological Characteristics and Therapeutic Management of Non-cholera Vibrio Infections
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 67
- 试验地点
- 7
- 主要终点
- Number of Participants With Diagnosed Non-cholerae or Non-O1/O139 Vibrio Infection
研究概览
简要总结
The purpose of this study is to identify the epidemiological and clinical characteristics of patients diagnosed with non-cholera Vibrio infection in Western France from 2000 to 2019.
详细描述
Vibrios are gram-negative, ubiquitous bacteria of the marine flora and are found particularly in warm waters. For example, the incidence is high in Florida and Vibrio infections are now reportable in the United States. Different species of Vibrio are described. A distinction is made between choleric vibrios belonging to serogroups O1 and O139, responsible for cholera epidemics, and non-choleric vibrios. Our study will focus on non-cholera vibrios. Vibrio infections can occur by eating contaminated raw seafood or by exposure of a wound to the marine environment. They occur mainly during the hot summer months. This can be explained on the one hand by higher water temperature and on the other hand by increased beach use. With global warming, it is possible that Vibrio infections may increase in number and location.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •non-cholera Vibrio infection
排除标准
- •vibriosis to Vibrio cholerae O1 and O139
结局指标
主要结局
Number of Participants With Diagnosed Non-cholerae or Non-O1/O139 Vibrio Infection
时间窗: Up to 20 years, from 2000-2019
A non-cholerae or non-O1/O139 Vibrio infection was defined by a biological sample (blood, superficial sample, deep sample, and ear sample) positive to a Vibrio species other than Vibrio cholerae O1-O139.
次要结局
- Number of Participants Associated With Environmental Factors(at inclusion)
- Number of Participants Per Identified Species(at inclusion)
- Number of Participants by Month of the Years(at inclusion)
- Number of Participants Treated by Antibiotics(through study completion, an average of 1 month)
- Number of Patients Per Clinical History(at inclusion)
- Number of Participants Per Outcome(through study completion, an average of 1 month)